| Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation RJ Berckmans, R Nieuwland, AN Böing, FP Romijn, CE Hack, A Sturk Thrombosis and haemostasis 85 (04), 639-649, 2001 | 856 | 2001 |
| A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study) A Gringeri, B Lundin, S Von Mackensen, L Mantovani, PM Mannucci, ... Journal of Thrombosis and Haemostasis 9 (4), 700-710, 2011 | 550 | 2011 |
| A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study J Astermark, SM Donfield, DM DiMichele, A Gringeri, SA Gilbert, J Waters, ... Blood 109 (2), 546-551, 2007 | 543 | 2007 |
| A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study J Astermark, SM Donfield, DM DiMichele, A Gringeri, SA Gilbert, J Waters, ... Blood 109 (2), 546-551, 2007 | 543 | 2007 |
| Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group A Gringeri, LG Mantovani, L Scalone, PM Mannucci, COCIS Study Group Blood 102 (7), 2358-2363, 2003 | 437 | 2003 |
| Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review A Iorio, S Halimeh, S Holzhauer, N Goldenberg, E Marchesini, M Marcucci, ... Journal of Thrombosis and Haemostasis 8 (6), 1256-1265, 2010 | 327 | 2010 |
| European principles of haemophilia care BT Colvin, J Astermark, K Fischer, A Gringeri, R Lassila, W Schramm, ... Haemophilia 14 (2), 361-374, 2008 | 298 | 2008 |
| Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses PM Mannucci, S Gdovin, A Gringeri, M Colombo, A Mele, N Schinaia, ... Annals of internal medicine 120 (1), 1-7, 1994 | 294 | 1994 |
| Consensus perspectives on prophylactic therapy for haemophilia: summary statement E Berntorp, J Astermark, S Björkman, VS Blanchette, K Fischer, ... Haemophilia 9, 1-4, 2003 | 292 | 2003 |
| CC chemokines, pivotal in protection against HIV type 1 infection D Zagury, A Lachgar, V Chams, LS Fall, J Bernard, JF Zagury, B Bizzini, ... Proceedings of the National Academy of Sciences 95 (7), 3857-3861, 1998 | 267 | 1998 |
| Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors C Leissinger, A Gringeri, B Antmen, E Berntorp, C Biasoli, S Carpenter, ... New England Journal of Medicine 365 (18), 1684-1692, 2011 | 263 | 2011 |
| Quality‐of‐life differences between prophylactic and on‐demand factor replacement therapy in European haemophilia patients S Royal, W Schramm, E Berntorp, P Giangrande, A Gringeri, C Ludlam, ... Haemophilia 8 (1), 44-50, 2002 | 254 | 2002 |
| Interferon α and Tat involvement in the immunosuppression of uninfected T cells and CC chemokine decline in AIDS D Zagury, A Lachgar, V Chams, LS Fall, J Bernard, JF Zagury, B Bizzini, ... Proceedings of the National Academy of Sciences 95 (7), 3851-3856, 1998 | 229 | 1998 |
| Active anti-interferon-α immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study) A Gringeri, M Musicco, P Hermans, Z Bentwich, M Cusini, A Bergamasco, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 20 (4), 358-370, 1999 | 204 | 1999 |
| Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. JF Zagury, A Sill, W Blattner, A Lachgar, H Le Buanec, M Richardson, ... Journal of human virology 1 (4), 282-292, 1998 | 187 | 1998 |
| The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study DB Brettler, PM Mannucci, A Gringeri, JE Rasko, AD Forsberg, MG Rumi, ... Blood 80 (2), 540-543, 1992 | 182 | 1992 |
| High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels MG Rumi, M Colombo, A Gringeri, PM Mannucci Annals of internal medicine 112 (5), 379-380, 1990 | 180 | 1990 |
| Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report J Astermark, C Altisent, A Batorova, MJ Diniz, A Gringeri, PA Holme, ... Haemophilia 16 (5), 747-766, 2010 | 178 | 2010 |
| Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors L Scalone, LG Mantovani, PM Mannucci, A Gringeri, ... Haemophilia 12 (2), 154-162, 2006 | 178 | 2006 |
| Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy SM Siboni, PM Mannucci, A Gringeri, M Franchini, A Tagliaferri, M Ferretti, ... Journal of Thrombosis and Haemostasis 7 (5), 780-786, 2009 | 163 | 2009 |
